Antithrombin III activity, von Willebrand factor antigen and platelet function in young diabetic patients treated with multiple insulin injections versus insulin pump treatment

This publication has 21 references indexed in Scilit:

• Metabolic Control May Alter Antithrombin III Activity but Not Its Plasma Concentration in Diabetes: A Possible Role for Nonenzymatic Glycosylation
  Diabetes Care, 1986
• Clinical Experience with a New Device that Will Simplify Insulin Injections
  Diabetes Care, 1985
• Platelets and Diabetes Mellitus
  New England Journal of Medicine, 1984
• Continuous Subcutaneous Insulin Infusion (Mill-Hill Infuser) Versus Multiple Injections (Medi-Jector) in the Treatment of Insulin-dependent Diabetes Mellitus and the Effect of Metabolic Control on Microangiopathy
  Diabetes Care, 1984
• Inhibition of heparin-catalyzed human antithrombin III activity by nonenzymatic glycosylation. Possible role in fibrin deposition in diabetes
  Diabetes, 1984
• A new automated technique for platelet aggregation measurement
  Scandinavian Journal of Clinical and Laboratory Investigation, 1984
• A crossover comparison of continuous subcutaneous insulin infusion (CSII) against multiple insulin injections in insulin-dependent diabetic subjects: improved control with CSII
  Diabetes Care, 1982
• Tyrosine A14[125I]monoiodoinsulin: Preparation, Biologic Properties, and long-term stability
  Diabetes, 1981
• Plasma Antithrombin III and Thrombin Generation Time: Correlation with Hemoglobin A1 and Fasting Serum Glucose in Young Diabetic Women
  Diabetes Care, 1980
• Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia.
  BMJ, 1978